GATEWAY INVESTMENT ADVISERS LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1114618
CINCINNATI, OH
Position in HALO
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$634,847
New position
Shares Held
8,111
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#357
of 664 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026GATEWAY INVESTMENT ADVISERS LLC holds $83,759,285 across 16 Biotechnology names. HALO ranks #8 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
365,000 | $38,916,300 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
67,289 | $33,424,464 | |
| 3 | INCY |
Incyte Corp
|
23,398 | $2,652,397 | |
| 4 | EXEL |
Exelixis, Inc.
|
43,083 | $2,344,146 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
22,728 | $1,300,496 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
4,123 | $993,519 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,900 | $872,987 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
This page
|
8,111 | $634,847 |
All Filings in HALO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $634,847 | 8,111 | Shares | Sole | 2026-07-20 | |
| No filing history on record for this holder in this stock. | ||||||